Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
US Payrolls Beat Expectations but Report Signals Underlying Economic Weaknesses JPMorgan Discloses 20 Billion Acquisition Spending Nifty and Bank Nifty Futures Encounter Stiff Resistance as June Series Shows Mixed Positioning Nifty 50 Drops Over 100 Points After Reclaiming 24000 Geopolitical Jitters Spark Volatility Companies Continue Betting on Prediction Markets Amid Regulatory Uncertainty TEAD Q1 2026 Earnings Narrowed Loss Beats Expectations as Cost Discipline Shines ADAMH Q1 2026 Earnings Strong EPS Surprise Highlights Solid Underlying Performance Danaher Corporation DHR Q1 2026 Earnings EPS Beats Estimates by 531 Amid Mixed Disclosures XOMAP Q1 2026 Earnings Perpetual Preferred Faces Steep EPS Miss Amid Limited Revenue Visibility Noodles Company NDLS Q1 2026 Earnings Loss Per Share of 044 as Stock Declines 315 ZOOZ Strategy Ltd Warrant ZOOZW Surges 5789 as Speculative Interest Builds BioCryst Pharmaceuticals BCRX Surges 626 as Momentum Builds Above Key Support X3 Acquisition Corp Ltd Warrant XCBEW Holds Steady at 026 Tight Range Reflects Limited Momentum NewtekOne Fixed Rate Notes Hold Steady at 260 as Support and Resistance Levels Come into Focus Claiming Average Social Security Benefit Early High Job Earnings Could Lead to Zero Payment in 2026 The Pokmon Card Boom Nostalgia Celebrity Hype and Speculation Fuel a MultiMillionDollar Market SpaceX Completes Starship Test Flight After Previous Scrub Marking Step Forward for Commercial Space Sector MicroVision Reports Surge in Gross Margin to 39 Following Luminar Lidar Acquisition Roth Capital Raises Price Target on The Beachbody Company Following Q1 Results Nationwide Faces Pressure Over Governance Concerns Ahead of AGM Lyft Under 15 RideHailing Stock Draws Market Attention BofA Upgrades Outlook for Philip Morris International with 9 Price Target Increase Morning Squawk Micron Milestone Dicks Earnings Paxton Defeats Cornyn Lead Investor Agenda Viridian Therapeutics Prices Upsized 350M Concurrent Public Offerings